DEL MASTRO, LUCIANA
 Distribuzione geografica
Continente #
AS - Asia 112
EU - Europa 74
NA - Nord America 59
SA - Sud America 17
AF - Africa 3
Totale 265
Nazione #
US - Stati Uniti d'America 58
SG - Singapore 57
IT - Italia 28
HK - Hong Kong 23
CN - Cina 19
BR - Brasile 16
RU - Federazione Russa 11
DE - Germania 7
IE - Irlanda 7
KR - Corea 7
FR - Francia 5
VN - Vietnam 4
AT - Austria 3
FI - Finlandia 3
SE - Svezia 3
GB - Regno Unito 2
NL - Olanda 2
RO - Romania 2
TG - Togo 2
AM - Armenia 1
CA - Canada 1
EC - Ecuador 1
LT - Lituania 1
MA - Marocco 1
NP - Nepal 1
Totale 265
Città #
Singapore 47
Hong Kong 23
Ashburn 8
Boardman 8
Udine 8
Beijing 7
Dublin 7
Hefei 7
Seoul 7
Chandler 5
Dong Ket 4
New York 4
Frankfurt am Main 3
Lauterbourg 3
Nuremberg 3
Ogden 3
Amsterdam 2
Belluno 2
Galliate 2
Helsinki 2
Lomé 2
Los Angeles 2
Nanning 2
Poggiomarino 2
Princeton 2
San Diego 2
Vienna 2
Washington 2
Barra de São Francisco 1
Betim 1
Brooklyn 1
Bucharest 1
Cabo de Santo Agostinho 1
Cambé 1
Campinas 1
Canoas 1
Cayambe 1
Codroipo 1
Curno 1
Düsseldorf 1
Formiga 1
Imaruí 1
Kathmandu 1
Lappeenranta 1
Maceió 1
Manaus 1
Maranguape 1
Mogi das Cruzes 1
Naples 1
Newark 1
Plymouth 1
Porcia 1
Portsmouth 1
Quzhou 1
Rome 1
Salvador 1
San Francisco 1
Stockholm 1
São Bento do Sul 1
São João de Meriti 1
Toronto 1
Treviso 1
Veranópolis 1
Vilnius 1
Wilmington 1
Yerevan 1
Totale 209
Nome #
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 45
Tailoring adjuvant endocrine therapy in early breast cancer: When, how, and how long? 39
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review 37
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests 36
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial 34
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants 32
New steps on an old path: Novel estrogen receptor inhibitors in breast cancer 26
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays? 25
Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real world 17
Totale 291
Categoria #
all - tutte 2.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/20228 0 0 0 2 0 0 0 1 0 2 1 2
2022/202347 4 0 10 4 2 14 5 0 3 5 0 0
2023/202436 2 0 2 0 3 6 0 1 3 6 2 11
2024/2025190 3 10 0 2 21 13 20 12 22 17 39 31
Totale 291